How should we assess and pay? Health-economic assessments and payment models for precision medicines and ATMPs – 2021

In this report, TLV describes the challenges we consider to be most critical to health economic assessments of precision medicine and ATMP, and also provide suggestions for meeting some of these challenges. In addition, we outline our view of the opportunities for using new types of payment models for ATMP.